Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Apr 4, 2017
Insider Transaction Report
Form 4
Hanna Ashraf
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2017-03-31$0.13/sh+500$63→ 11,920 total - Exercise/Conversion
Restricted Share Units
2017-03-31−500→ 500 totalExercise: $0.13Exp: 2019-07-01→ Ordinary Shares (500 underlying)
Holdings
- 1,500(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]500 of the Restricted Share Units vested and became convertible on 03/31/17, and 500 Restricted Share Units shall vest and become convertible on 6/30/17, subject to payment of the nominal value per share to Issuer within 30 days of vesting.